Li Shi

Dr. Li Shi

Shanghai Institute of Materia Medica, Chinese Academia of Sciences
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2020 in The FEBS Journal
Verified
Journal Article
Open access
PDF file
HWHui Wang
Hui Wang
QMQian Meng
Qian Meng
YDYiluan Ding
Yiluan Ding
MXMuya Xiong
Muya Xiong
MZMengying Zhu
Mengying Zhu
NZNaixia Zhang
Naixia Zhang
Deubiquitinase USP28 plays a crucial role in tumorigenesis by enhancing the stabilities of multiple cancer‐related proteins including c‐Myc, Notch1, and LSD1, and has become an attractive target for anticancer drug development. However, to date, only a few of USP28‐targeted active compounds have been developed, and the active compound‐binding pocket in USP28 has not been experimentally revealed yet. In this study, bioassay‐based high‐throughput screening was applied to discover USP28‐targeted inhibitors from the commercially available drug library. Vismodegib, an inhibitor of Hedgehog signaling pathway and FDA‐approved drug for the treatment of basal cell carcinoma, was found to exhibit inhibition activity against USP28 (IC50: 4.41 ± 1.08 μm). Multiple biophysical and biochemical techniques including NMR, ITC, thermal shift assay, HDX‐MS, and site‐directed mutagenesis analysis were then used to characterize the interaction between Vismodegib and USP28. The binding pocket in USP28 for Vismodegib, which is mainly composed of two helical structures spanning D255‐N278 and N286‐Y293, was revealed. According to the possible binding pose generated by HDX‐MS data‐defined molecular docking, the binding cavity occupied by Vismodegib in USP28 aligns well with one of the reported‐binding pockets in USP7 for its inhibitors. Furthermore, cellular assays were conducted to confirm that Vismodegib could interact with the evolutionarily related deubiquitinases USP28 and USP25 and downregulate the levels of the two enzymes' substrate proteins c‐Myc, Notch1, and Tankyrase‐1/2.

22 January 2021 in Molecules
Verified
Journal Article
Open access
PDF file
Li ShiLi Shi
Li Shi
NZNaixia Zhang
Naixia Zhang
During the past decades, solution nuclear magnetic resonance (NMR) spectroscopy has demonstrated itself as a promising tool in drug discovery. Especially, fragment-based drug discovery (FBDD) has benefited a lot from the NMR development. Multiple candidate compounds and FDA-approved drugs derived from FBDD have been developed with the assistance of NMR techniques. NMR has broad applications in different stages of the FBDD process, which includes fragment library construction, hit generation and validation, hit-to-lead optimization and working mechanism elucidation, etc. In this manuscript, we reviewed the current progresses of NMR applications in fragment-based drug discovery, which were illustrated by multiple reported cases. Moreover, the NMR applications in protein-protein interaction (PPI) modulators development and the progress of in-cell NMR for drug discovery were also briefly summarized.

1 January 2024 in American Journal of Cancer Research
Verified
Journal Article
Closed access
ZXZhuo Xu
Zhuo Xu
NZNaixia Zhang
Naixia Zhang
Li ShiLi Shi
Li Shi
Deubiquitinating enzymes (DUBs) are a large group of proteases that reverse ubiquitination process and maintain protein homeostasis. The DUBs have been classified into seven subfamilies according to their primary sequence and structural similarity. As a small subfamily of DUBs, the ubiquitin C-terminal hydrolases (UCHs) subfamily only contains four members including UCHL1, UCHL3, UCHL5, and BRCA1-associated protein-1 (BAP1). Despite sharing the deubiquitinase activity with a similar catalysis mechanism, the UCHs exhibit distinctive biological functions which are mainly determined by their specific subcellular localization and partner substrates. Besides, growing evidence indicates that the UCH enzymes are involved in human malignancies. In this review, the structural information and biological functions of the UCHs are briefly described. Meanwhile, the roles of these enzymes in tumorigenesis and the discovered inhibitors against them are also summarized to give an insight into the cancer therapy with the potential alternative strategy.

11 April 2023 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
DZDi Zhou
Di Zhou
ZXZhuo Xu
Zhuo Xu
YHYaodong Huang
Yaodong Huang
HWHui Wang
Hui Wang
XZXiaoli Zhu
Xiaoli Zhu
BXBing Xiong
Bing Xiong

12 August 2023 in Biochemical Pharmacology
Verified
Journal Article
Closed access
ZXZhuo Xu
Zhuo Xu
HWHui Wang
Hui Wang
QMQian Meng
Qian Meng
YDYiluan Ding
Yiluan Ding
MZMengying Zhu
Mengying Zhu
Li ShiLi Shi
Li Shi

1 January 2010 in Perspectives chinoises
Verified
Journal Article
Open access
Li ShiLi Shi
Li Shi
Cet article s’intéresse à la situation économique actuelle des travailleurs migrants d’origine rurale en Chine. Il présente des statistiques sur leur région de départ, leur destination et les secteurs dans lesquels ils sont employés, sur leur âge, leur sexe et leur niveau d’éducation. Il analyse également les conditions de travail de nombreux migrants, notamment la faiblesse de leurs revenus, le problème des arriérés de salaires, l’absence de contrats de travail écrits, le temps de travail, les failles de la couverture sociale, et les difficultés d’accès aux services publics.Shi Li. La situation économique des travailleurs migrants d’origine rurale en Chine. In: Perspectives chinoises, n°113, 2010. pp. 4-16